T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 02/28/2019
Domestic Stock 59.6%
Domestic Bond 25.1%
Cash 8.3%
Convertibles 2.5%
Preferreds 2.2%
Foreign Stock 1.7%
Foreign Bonds 0.8%
Other 0.1%
Options -0.3%
Volatility and Other Measures
as of 02/28/2019
Beta 0.62
Active Share 77.33
Standard Deviation 7.22
Price/Earnings Ratio (Domestic) 21.4
Earnings Growth Rate (Domestic) 11.5
Turnover Rate 9.2
Median Market
$57,591.14 Million
Sector Diversification
as of 02/28/2019
% of Total Net Assets
Health Care 15.3%
Information Technology 14.1%
Financials 9.3%
Industrials & Business Services 8.0%
Utilities 5.9%
Consumer Discretionary 5.1%
Communication Services 3.7%
Energy 1.1%
Real Estate 0.8%
Consumer Staples 0.3%
T. Rowe Price uses the current MSCI/S&P Global Industry Classification Standard (GICS) for sector and industry reporting. T. Rowe Price will adhere to all updates to GICS for prospective reporting.
10 Largest Holdings
Represents 30.39 % of Total Net Assets
View Holdings as of:
Becton, Dickinson & Company
Marsh & McLennan
Thermo Fisher Scientific
United States Treasury Note/Bond
As of 02/28/2019 the Capital Appreciation Fund had a total of 263 holdings.
See Glossary for additional details on all data elements.